Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-17.02	98.01	118.12
Graham Fair Price	3.92	7.68	7.39
PEG	89.50	-1.26	-11.99
Price/Book	35.31	-13.20	-20.40
Price/Cash Flow	230.82	129.88	39.26
Prices/Earnings	-8.21	30.57	33.30
Price/Sales	-9.43	11.93	13.17
Price/FCF	230.82	129.88	39.26
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.00	0.71	0.70
Operating Margin	-23.10	0.11	0.14
ROA	-18.65	0.03	0.03
ROE	-0.15	-0.11	29.52
ROIC	0.05	0.03	-37.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	10.68
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.30	-0.41	35.05
EPS QOQ	-0.03	-0.24	-774.29
FCF QOQ	0.36	-0.79	118.91
Revenue QOQ	0.32	-0.23	-28.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	31.00	35.68	15.10
Inventory Turnover	255757000.00	0.00	inf
Debt/Capitalization	1.29	1.32	2.22
Quick Ratio	2.03	2.30	13.48
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-3.98	-4.93	-23.78
Cash	8.42	8.81	4.60
Capex	-0.09	-0.08	10.86
Free Cash Flow	2.07	0.50	-75.79
Revenue	6.17	5.45	-11.59
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.21	2.49	12.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.86	16.86	21.57
Naive Interpretation	Member

06 - Financial Health · Bad

Rating